OpenEvidence, which is valued at $425 million, is taking on one of AI’s big engineering challenges: large language models whose training is stuck in the past.
Amazon is continuing its expansion into the health space with the launch of a new generative AI tool called HealthScribe, meant to take over some time-consuming administrative tasks of doctor’s offices and clinics, the company said.
Researchers develop a new organoid model of the liver that reveals key molecules involved in liver regeneration and may lead to new treatments for chronic liver diseases.
Hospitals on average aren’t performing as well financially as they were before the pandemic, thanks to the labor shortage and need for nurses in particular.